BioSpace News Archive

AzurRx BioPharma, Inc. announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 5,454,546 shares of common stock of the Company, at a price to the public of $0.55 per share, less underwriting discounts and commissions.

The growing demand from biomarkers and the rising applications of transcriptomics technologies across the globe will prove to be a boon for the growth of the spatial OMICS market during the assessment period of 2020-2030.

The demand within the global sharps containers market is slated escalate in the years to follow.

Shoulder replacement is a surgical procedure that replaces the original ball and socket surfaces of the shoulder with similar shaped prosthetic implants.

Natera, Inc today announced the pricing of its underwritten public offering of 4,500,000 shares of its common stock at a price to the public of $113.00 per share. Closing of the offering is expected to occur on July 26, 2021.

Holter monitor is used in non-invasive techniques to monitor cardiac rhythm over a long period of time.

A thoracic surgery involves any procedure or operation related to chest organs including heart, lungs, esophagus, and trachea.

Titan Medical Inc. today announced that David McNally, President and CEO of Titan Medical, and Stephen Lemieux, Chief Financial Officer, will be meeting with investors during the Alliance Global Partners Virtual MedTech Summer Investor Conference on Thursday, July 29, 2021.

ZYUS Life Sciences Inc. announced today that its wholly owned U.S. subsidiary, ZYUS Life Sciences U.S. Ltd. has received one patent allowance notification and two patent issuances from the United States Patent and Trademark Office (USPTO).

IN8bio, Inc. today announced that it has launched an initial public offering of 4,000,000 shares of its common stock.